Skip to main content
SpringerLink
Log in

Study of a luminescent and antibacterial biomaterial based on hydroxyapatite as support for an antineoplastic drug

  • Article
  • Published:
Journal of Materials Research Aims and scope Submit manuscript

Abstract

In this work, a multifunctional system was developed in which antibacterial and luminescent properties were inserted into the matrix of hydroxyapatite (HAp) and its efficiency as a support for an antineoplastic drug was evaluated, aiming its application in the treatment of osseous diseases. The precipitation method was used for the synthesis of HAp, EuCl3 was used for the incorporation of Eu3+ as imaging agents, silver nanoparticles (AgNPs) with antimicrobial function were used, and a model of drug, 5-fluorouracil (5FU) was used. The developed material is characterized by several techniques, where crystalline peaks attributed to HAp were identified in the X-ray diffractogram, whereas the luminescence spectrum of the material presented emissions attributed to the Eu3+ ion. The identification and the uniform distribution of AgNPs, 5FU, and Eu3+ were confirmed by mapping the sample using energy-dispersive spectroscopy. The measurements indicated that 82% (±2.8) of 5FU was incorporated into the HAp matrix, and a gradual and increasing release of it as a function of time was observed. Assays carried out for different bacteria confirmed the antimicrobial action of the samples and the efficiency of the drug inserted into the matrix. An in vitro assay showed the bioactivity of the material and its potential to bind to living osseous tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1:
Figure 2:
Figure 3:
Figure 4:
Figure 5:
Figure 6:
Figure 7:
Figure 8:
Figure 9:

Similar content being viewed by others

References

  1. L. Ouyang, D. He, J. Zhang, G. He, B. Jiang, Q. Wang, Z. Chen, J. Pan, Y. Li, and L. Guo: Selective bone targeting 5-fluorouracil prodrugs: Synthesis and preliminary biological evaluation. Bioorg. Med. Chem. 19, 3750–3756 (2011).

    Article  CAS  Google Scholar 

  2. J.T. Buijs and G.V. Pluijm: Osteotropic cancers: From primary tumor to bone. Cancer Lett. 273, 177–193 (2009).

    Article  CAS  Google Scholar 

  3. H. Hirabayashi and J. Fujisaki: Bone-specific drug delivery systems approaches via chemical modification of bone-seeking agents. Clin. Pharmacokinet. 42, 1319–1330 (2003).

    Article  CAS  Google Scholar 

  4. J. Cawthray, E. Wasan, and K. Wasan: Bone-seeking agents for the treatment of bone disorders. Drug Delivery Transl. Res. 7, 466–481 (2017).

    Article  CAS  Google Scholar 

  5. E. Andronescu, M. Ficai, G. Voicu, D. Ficai, M. Maganu, and A. Ficai: Synthesis and characterization of collagen/hydroxyapatite: Magnetite composite material for bone cancer treatment. J. Mater. Sci.: Mater. Med. 21, 2237–2242 (2010).

    CAS  Google Scholar 

  6. C. Marques, J.M.F. Ferreira, E. Adronescu, D. Ficai, M. Sonmez, and A. Ficai: Multifunctional materials for bone cancer treatment. Int. J. Nanomed. 9, 2713–2725 (2014).

    Google Scholar 

  7. R. Kuehl, P.S. Brunetto, A.K. Woischnig, M. Varisco, Z. Rajacic, Vosbeck, L. Terracciano, K.M. Fromm, and N. Khanna: Preventing implant-associated infections by silver coating. Antimicrob. Agents Chemother. 60, 2467–2475 (2016).

    Article  CAS  Google Scholar 

  8. A.M. Costa and V.V. Silva: Nanotechnology strategies for diagnosis and treatment of cancer. R. Saúde Meio Amb. 5, 1–13 (2017).

    Google Scholar 

  9. Y. Liu, H. Miyoshi, and M. Nakamura: Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int. J. Cancer 120, 2527–2537 (2007).

    Article  CAS  Google Scholar 

  10. J.R. Lopes, J.A. Oliveira, and A.A. Esteves: Synthesis and characterization of hydroxyapatite powders [Ca10(PO4)6(OH)2] obtained from the sol–gel process. Foco 6, 55–72 (2015).

    Google Scholar 

  11. K. Lin and J. Chang: Structure and properties of hydroxyapatite for biomedical applications. Hydroxyapatite Biomed. Appl., 3–19 (2015). doi: https://doi.org/10.1016/B978-1-78242-033-0.00001-8.

  12. A. Ashokan, D. Menon, S. Nair, and M. Koyakutty: A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent. Biomaterials 31, 2606–2616 (2010).

    Article  CAS  Google Scholar 

  13. F. Chen, P. Huang, Y.J. Zhu, J. Wu, C.L. Zhang, and D.X. Cui: The photoluminescence, drug delivery and imaging properties of multifunctional Eu3+/Gd3+ dual-doped hydroxyapatite nanorods. Biomaterials 32, 9031–9039 (2011).

    Article  CAS  Google Scholar 

  14. S.V. de Oliveira, S.N. Cavalcanti, G.P. Rabelo, E.M. Araújo, and M.V.L. Fook: Hydroxyapatite infrared analysis. In VI Congr. Nac. Eng. Mec. (Conem), Campina Grande, PB, 2010.

  15. C.L. Tseng, J.C. Chen, Y.C. Fang, F.H. Lin, and T.P. Tang: Development of lattice-inserted 5-fluorouracil-hydroxyapatite nanoparticles as a chemotherapeutic delivery system. J. Biomater. Appl. 30, 388–397 (2015).

    Article  CAS  Google Scholar 

  16. P. Singh, G. Tyagi, R. Mehrotra, and A. Bakhshi: Thermal stability studies of 5-fluorouracil using diffuse reflectance infrared spectroscopy. Drug Test. Anal. 1, 240–244 (2009).

    Article  CAS  Google Scholar 

  17. K.S.W. Sing, D.H. Everett, R.A.W. Haul, L. Moscou, R.A. Pirotti, and J. Rouquerol: Reporting physisorption data for gas/solid systems in. Pure Appl. Chem. 57, 603–619 (1985).

    Article  CAS  Google Scholar 

  18. Y. Jin, A. Wang, G. Wu, H. Yin, S. Liu, B. Chen, F. Liu, and X. Li: Synthesis of different sized and porous hydroxyapatite nanorods without organic modifiers and their 5-fluorouracil release performance. Mater. Sci. Eng., C 57, 14–23 (2015).

    Article  Google Scholar 

  19. P. Martin, G. Carlot, A. Chevarier, C. Den-Auwer, and G. Panczer: Mechanisms involved in thermal diffusion of rare earth elements in apatite. J. Nucl. Mater. 275, 268–276 (1999).

    Article  CAS  Google Scholar 

  20. L.A. Zavala-Sanchez, G.A. Hirata, E. Novitskaya, K. Karandikar, M. Herrera, and O.A. Graeve: Distribution of Eu2+ and Eu3+ ions in hydroxyapatite: A cathodoluminescence and Raman study. ACS Biomater. Sci. Eng. 1, 1306–1313 (2015).

    Article  CAS  Google Scholar 

  21. O.A. Graeve, R. Kanakala, A. Madadi, B.C. Williams, and K.C. Glass: Luminescence variations in hydroxyapatites doped with Eu2+ and Eu3+ ions. Biomaterials 31, 4259–4267 (2010).

    Article  CAS  Google Scholar 

  22. ANVISA: Standardization of Antimicrobial Susceptibility Tests by Disk-Diffusion: Standard Approved, Octave ed. (2003); p. 23, ISBN 1-56238-485-6.

  23. K.L. Nair, S. Jagadeeshan, S.A. Nair, and G.S. Kumar: Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier. PLGA. Int. J. Nanomedic. 6, 1685–1697 (2011).

    CAS  Google Scholar 

  24. H. Luo, D. Ji, C. Li, Y. Zhu, G. Xiong, and Y. Wan: Layered nanohydroxyapatite as a novel nanocarrier for controlled delivery of 5-fluorouracil. Int. J. Pharm. 513, 17–25 (2016).

    Article  CAS  Google Scholar 

  25. J.G. Hardman, L.E. Limbird, and A.G. Gilman: Goodman & Gilman’s the Pharmacological Basis of Therapeutics, 10th ed. (McGraw-Hill, New York, 2001). Available at: https://pt.wikipedia.org/wiki/Especial:Fontes_de_livros/0071354697. ISBN 0-07-135469-7.

    Google Scholar 

  26. S.D. Solomon, M. Bahadory, A.V. Jeyarajasigam, S.A. Rutkowsky, and C. Boritz: Synthesis and study of silver nanoparticles. J. Chem. Educ. 84, 322–325 (2007).

    Article  CAS  Google Scholar 

  27. T. Kokubo and H. Takadama: How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 27, 2907–2915 (2006).

    Article  CAS  Google Scholar 

Download references

Acknowledgment

This research was supported by Foundation for protection of research in the state of Bahia—FAPESB.

Author information

Authors and Affiliations

  1. Department of Materials Science, Federal University of Pernambuco, Recife, PE, 50740-560, Brazil

    Amanda Alves Barbosa & Severino Alves Júnior

  2. Department of Materials Science, Federal University of San Francisco Valley, Juazeiro, BA, 48902-300, Brazil

    Amanda Alves Barbosa & Andréa de Vasconcelos Ferraz

Authors
  1. Amanda Alves Barbosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Severino Alves Júnior
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andréa de Vasconcelos Ferraz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amanda Alves Barbosa.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barbosa, A.A., Júnior, S.A. & de Vasconcelos Ferraz, A. Study of a luminescent and antibacterial biomaterial based on hydroxyapatite as support for an antineoplastic drug. Journal of Materials Research 34, 1922–1930 (2019). https://doi.org/10.1557/jmr.2019.139

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1557/jmr.2019.139

Search

Navigation